Kiora Pharmaceuticals Inc. Price to FCF Ratio 2015–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Kiora Pharmaceuticals Inc. (KPRX): market cap divided by trailing twelve-month free cash flow. As of September 30, 2025 it is 1.42.

From: 06/30/2016To: 09/30/2025

Stock Price

TTM Free Cash Flow

Price to FCF

Kiora Pharmaceuticals Inc. Price to FCF Ratio — FAQ

Kiora Pharmaceuticals Inc. (KPRX) price to fcf ratio over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KPRX's price to fcf ratio history?

The chart and table above show Kiora Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.